Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy.
Lin YangLiang WangYangyang DengLizhe SunBowen LouZuyi YuanYue WuBo ZhouJunhui LiuJianqing ShePublished in: Lipids in health and disease (2020)
Using non-targeted lipidomics profiling, we have successfully identified a group of circulating lipids that were significantly altered in IHD and ICM. The lipids metabolic signatures shed light on potential new biomarkers and therapeutics for preventing and treating ICM.